Clinical Trials
21 trialsNCT00602667 2026-05-19
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT07564453 2026-05-04
FLOW
The First Affiliated Hospital of Soochow University
Phase 2 Recruiting
NCT07559045 2026-04-30
Induction Chemo-Immunotherapy + Radiotherapy vs Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital of Zunyi Medical University
Phase 2 Recruiting
NCT07259473 2026-01-07
Pre-CATALIS
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT06906887 2025-06-29
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Medical College of Wisconsin
Phase 2 Recruiting
NCT07015489 2025-06-11
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
NCT05628922 2022-11-29
Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Fudan University
Phase 2 Recruiting
NCT04143984 2022-04-29
Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center
Phase 2 Unknown
NCT05232552 2022-02-10
Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT05054959 2021-09-23
ICONA
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT01491737 2020-10-28
PERTAIN
Hoffmann-La Roche
Phase 2 Completed
NCT04296747 2020-03-05
Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT02054819 2019-08-21
Treating NSCLC Minimal Stage IV With Curative Intent
Leo W. Jenkins Cancer Center
Phase 2 Terminated
NCT00167180 2019-07-30
Post Transplant Donor Lymphocyte Infusion
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT03161548 2017-05-30
A Study of Tongue Conservation Surgery for Oral Tongue Cancer
Taipei Veterans General Hospital, Taiwan
Phase 2 Terminated
NCT02084563 2016-11-08
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Hospital Israelita Albert Einstein
Phase 2 Completed
NCT00002735 2015-09-30
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
SWOG Cancer Research Network
Phase 2 Terminated
NCT00943553 2015-04-13
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Eisai Inc.
Phase 2 Withdrawn
NCT02187315 2014-07-11
Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study
Guiyang Medical University
Phase 2 Unknown
NCT00460551 2011-12-06
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
Genmab
Phase 2 Terminated
NCT01247493 2010-11-24
m-FLAI
Seoul National University Hospital
Phase 2 Completed